Samit Hirawat

Bristol Myers’ Hirawat on Pipeline Progress, Clinical Trial Diversity
Xconomy
Sun, 10/4/20 - 12:11 am
Bristol-Myers Squibb
Celgene
clinical trials
clinical trial diversity
Samit Hirawat